Current Guidelines for Germline Genetic Testing in Prostate Cancer May Be Insufficient

A high percentage of men with prostate cancer have 1 or more potentially pathogenic germline variants, but would not be eligible for mutation testing under current NCCN guidelines.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2GiIIMa